Catalyst Wire Dossier Catalyst Wire Dossier

DEFENCATH

taurolidine and heparin · CorMedix Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DEFENCATH, covering 2023-11-15 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) [Phase 3]

See pricing